A noncovalent dimer of the 22 kilodalton human growth hormone (22 K-hGH) is
known to have diminished somatogenic activity compared with monomeric 22 K
-hGH. In the present study, we examined the biological activity and physico
chemical behaviour of a noncovalent dimer of the 20 kilodalton human growth
hormone (20 K-hGH), an isoform of 22 K-hGH. Analysis of the equilibrium be
tween monomeric and associated forms revealed that the associated 20 K-hGH
was present in the dimeric form in aqueous solution. The kinetics of dimeri
zation in rat plasma followed the theory of dissociation-association equili
brium, and more than 99% of 20 K-hGH molecules existed as a monomer in the
equilibrium state at the physiological hGH concentration. Analysis of the p
harmacokinetics showed that the ratio of the administrated dimer in rat cir
culation decreased from 43% to less than 4% in 2 h. A preparation of noncov
alent dimeric 20 K-hGH had essentially the same degree of biological potenc
y as that of a monomer in both in vitro and in vivo bioassays. In conclusio
n, dimerization of 20 K-hGH is reversible both in vitro and in vivo and a n
oncovalent dimer can function as a pharmaceutically active component of a 2
0 K-hGH preparation, in contrast to a 22 K-hGH preparation. (C) 2000 Harcou
rt Publishers Ltd.